GPX4 and cancer: When SCD1/FADS2 was inhibited in cancer cells, the iron binding capacity decreased and the concentration of the LIP increased, leading to the accumulation of ROS and lipid peroxidation; with GPX4 also being downregulated, this led to ferroptosis.